Outcome of relapsed core binding factor acute myeloid leukemia in children: A result from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML‐05R study

Saved in:
Bibliographic Details
Published inPediatric blood & cancer Vol. 64; no. 10
Main Authors Moritake, Hiroshi, Tanaka, Shiro, Nakayama, Hideki, Miyamura, Takako, Iwamoto, Shotaro, Shimada, Akira, Terui, Kiminori, Saito, Akiko, Shiba, Norio, Hayashi, Yasuhide, Tomizawa, Daisuke, Taga, Takashi, Goto, Hiroaki, Hasegawa, Daisuke, Horibe, Keizo, Mizutani, Shuki, Adachi, Souichi
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.10.2017
Subjects
Acute myeloid leukemia
Adolescent
Anthracyclines - therapeutic use
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Child
Child, Preschool
Children
Core Binding Factors
Cytarabine - therapeutic use
Etoposide - therapeutic use
Granulocyte Colony-Stimulating Factor - therapeutic use
Hematology
Humans
Induction Chemotherapy - methods
Japan
Leukemia
Leukemia, Myeloid, Acute - drug therapy
Leukemia, Myeloid, Acute - pathology
Lymphoma
Mitoxantrone - therapeutic use
Myeloid leukemia
Oncology
Pediatrics
Proto-Oncogene Proteins c-kit - genetics
Recurrence
Retrospective Studies
Surveys and Questionnaires
Treatment Outcome
Vidarabine - analogs & derivatives
Vidarabine - therapeutic use
Japan
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:1545-5009
1545-5017
DOI:10.1002/pbc.26491